Related Experiment Video
Updated: Jan 31, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Left ventricular reverse remodeling in patients with anterior wall ST-segment elevation acute myocardial infarction
Marek Grabka1, Magdalena Kocierz-Woźnowska2, Maciej Wybraniec1
11 Department of Cardiology, Upper Silesian Medical Centre, Katowice, Poland.
Insights
Left ventricular reverse remodeling occurred in 37.5% of anterior ST-elevation myocardial infarction patients. Lower troponin and ST-segment elevation levels predicted this favorable remodeling, which was associated with fewer adverse events.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Interventional Cardiology
Background:
- Anterior ST-segment elevation myocardial infarction (STEMI) can lead to significant left ventricular (LV) dysfunction.
- Left ventricular reverse remodeling (LVRR) is a beneficial process that can improve outcomes after myocardial infarction.
- Understanding the prevalence, predictors, and prognostic implications of LVRR in anterior STEMI is crucial for patient management.
Purpose of the Study:
- To determine the prevalence of LVRR in patients following anterior STEMI.
- To identify predictors of LVRR in this patient population.
- To evaluate the impact of LVRR on long-term major adverse cardiovascular events (MACE).
Main Methods:
- An observational study involving 40 patients with first-ever anterior STEMI.
- LVRR defined as a reduction in left ventricular end-systolic volume (ΔLVESV) ≥ 10% at 3-month follow-up.
- Utilized 3D transthoracic echocardiography (3D-TTE) and cardiac magnetic resonance (CMR) for imaging; patients were followed for a median of 3.4 years for MACE.
Main Results:
- LVRR was observed in 37.5% of patients at 3-month follow-up.
- Predictors of LVRR included lower troponin levels, lower ST-segment elevation (pre- and post-PCI), lower maximal ST-segment elevation post-PCI, lower wall motion score index, and more negative anterior wall global longitudinal strain.
- Nine MACE occurred exclusively in the group without reverse remodeling, suggesting a potential protective effect.
Conclusions:
- LVRR develops in a significant proportion of anterior STEMI patients, even with optimal revascularization and pharmacotherapy.
- The study suggests LVRR may be associated with a better long-term prognosis, although this requires further investigation.
- Additional research is needed to fully elucidate the prognostic role of LVRR in predicting adverse cardiovascular events.
Introduction:
The study aimed to evaluate the prevalence and predictors of left ventricular (LV) reverse remodeling and its impact on long-term prognosis in patients with anterior ST-segment elevation myocardial infarction (STEMI).
Aim:
To assess the percentage of reverse remodeling and its prognostic factors in anterior STEMI patients.
Material And Methods:
This observational study included 40 patients with first ever STEMI of the anterior wall. LV reverse remodeling was defined as the reduction of left ventricular end-systolic volume (ΔLVESV) by ≥ 10% in 3D transthoracic echocardiography (3D-TTE) at 3-month follow-up. 3D-TTE and speckle tracking imaging were performed during index hospitalization, while 3D-TTE and cardiac magnetic resonance (CMR) were performed at 3 months following the procedure. Patients were followed up for a median time of 3.4 years in order to evaluate major adverse cardiovascular events.
Results:
Left ventricular reverse remodeling at 3-month follow-up was confirmed in 15 (37.5%) patients. The presence of reverse remodeling was predicted by lower troponin levels (unit OR = 0.86, p = 0.02), lower sum of ST-segment elevations before (unit OR = 0.87, p = 0.03) and after PCI (unit OR = 0.40, p = 0.03), lower maximal ST-segment elevation after PCI (unit OR = 0.01, p = 0.03), lower wall motion score index (unit OR 0.40, p = 0.03) and more negative anterior wall global longitudinal strain (unit OR = 0.88, p = 0.045). Nine MACE were reported in the without reverse remodeling group only. Non-significantly better event-free survival in the reverse remodeling group was demonstrated (log-rank p = 0.07).
Conclusions:
Development of reverse modeling in patients with optimal revascularization and tailored pharmacotherapy is relatively high. Further studies are warranted in order to adjudicate its prognostic role for the prediction of adverse events.
More Related Videos
09:37Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome V: Nursing Management
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care